학술논문
Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma
Document Type
Article
Author
Source
In Annals of Oncology June 2023
Subject
Language
ISSN
0923-7534